Cancer Of Prostate
43
13
16
18
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.3%
4 terminated out of 43 trials
81.8%
-4.7% vs benchmark
2%
1 trials in Phase 3/4
44%
8 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (43)
Collection of Blood From Patients With Prostate Cancer
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
Onco-primary Care Networking to Support TEAM-based Care
The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer
Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
Real-time Motion Management During Prostate and Lung Radiotherapy
Investigation of Three Biomarkers for the Detection of Prostate Cancer
Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
De-implementation of Low Value Castration for Men With Prostate Cancer